Abstract
Introduction/BackgroundVB10.16 is a novel therapeutic antigen-presenting cell targeting DNA vaccine developed to treat HPV16-positive cancers. We aimed to investigate whether VB10.16 is safe and efficacious when administered to patients with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have